NO20021309L - Preparat for IVF - Google Patents

Preparat for IVF

Info

Publication number
NO20021309L
NO20021309L NO20021309A NO20021309A NO20021309L NO 20021309 L NO20021309 L NO 20021309L NO 20021309 A NO20021309 A NO 20021309A NO 20021309 A NO20021309 A NO 20021309A NO 20021309 L NO20021309 L NO 20021309L
Authority
NO
Norway
Prior art keywords
ivf
preparation
phosperglycid
protein
prepared
Prior art date
Application number
NO20021309A
Other languages
English (en)
Other versions
NO20021309D0 (no
NO323694B1 (no
Inventor
Tina Meinertz Andersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO20021309L publication Critical patent/NO20021309L/no
Publication of NO20021309D0 publication Critical patent/NO20021309D0/no
Publication of NO323694B1 publication Critical patent/NO323694B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20021309A 1999-09-16 2002-03-15 Fast produkt som kan anvendes i forbindelse med fertilisering in vitro, anvendelse derav ved fremstilling av en vandig opplosning og fremgangsmate for fremstilling av en vandig opplosning. NO323694B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901308 1999-09-16
PCT/DK2000/000500 WO2001019354A2 (en) 1999-09-16 2000-09-11 Composition for ivf

Publications (3)

Publication Number Publication Date
NO20021309L true NO20021309L (no) 2002-03-15
NO20021309D0 NO20021309D0 (no) 2002-03-15
NO323694B1 NO323694B1 (no) 2007-06-25

Family

ID=8103409

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021309A NO323694B1 (no) 1999-09-16 2002-03-15 Fast produkt som kan anvendes i forbindelse med fertilisering in vitro, anvendelse derav ved fremstilling av en vandig opplosning og fremgangsmate for fremstilling av en vandig opplosning.

Country Status (21)

Country Link
US (1) US6844313B1 (no)
EP (1) EP1216059B1 (no)
JP (1) JP2003509365A (no)
KR (1) KR100757909B1 (no)
CN (1) CN1222319C (no)
AT (1) ATE306942T1 (no)
AU (1) AU781994B2 (no)
BR (1) BR0014058A (no)
CA (1) CA2382908A1 (no)
CZ (1) CZ2002591A3 (no)
DE (1) DE60023324T2 (no)
ES (1) ES2252048T3 (no)
HU (1) HUP0202630A3 (no)
IL (1) IL148234A0 (no)
MX (1) MXPA02002439A (no)
NO (1) NO323694B1 (no)
PL (1) PL202224B1 (no)
RU (1) RU2263516C2 (no)
UA (1) UA78183C2 (no)
WO (1) WO2001019354A2 (no)
ZA (1) ZA200201383B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1341147A (zh) * 1999-02-26 2002-03-20 诺沃挪第克公司 减数分裂活化甾醇增大着床率
IL148234A0 (en) 1999-09-16 2002-09-12 Novo Nordisk As Composition for ivf
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
US6988613B2 (en) 2001-02-06 2006-01-24 Novo Nordisk A/S Composition for IVF
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4175074A (en) 1976-08-23 1979-11-20 Deshmukh Arvind D Serum-soluble cholesterol compounds and method for their preparation
US4751219A (en) 1985-02-05 1988-06-14 Nederlandse Centrale Organisatie Voor Toegepast-Natuur-Wetenschappelijk Onderzoek Synthetic glycolipides, a process for the preparation thereof and several uses for these synthetic glycolipides
WO1990003429A1 (en) * 1988-09-23 1990-04-05 Cetus Corporation Lipid microemulsions for culture media
DE4221880A1 (de) 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen
JPH08503950A (ja) * 1992-12-02 1996-04-30 アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド 徐放性成長ホルモン含有マイクロスフェア
US5716777A (en) 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
US6281015B1 (en) * 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
CZ279797A3 (cs) 1995-03-06 1998-01-14 Novo Nordisk A/S Způsob stimulace miózy zárodečné buňky a použití sloučeniny, která způsobuje akumulaci látky aktivující endogenní miózu
BR9608968A (pt) 1995-06-23 1999-06-29 Novo Nordisk As Composto e processo para regular meiose em uma célula germinativa de mamífero
GB9625175D0 (en) * 1996-12-04 1997-01-22 Medi Cult As Serum-free cell culture media
JP2001506656A (ja) * 1996-12-20 2001-05-22 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
CA2289524A1 (en) 1997-06-04 1998-12-10 Akzo Nobel Nv 17.beta.-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
HUP9701554D0 (en) 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins
JP2002516272A (ja) 1998-05-26 2002-06-04 シエーリング アクチエンゲゼルシヤフト ｃＡＭＰを増大させる化合物を単独でまたは減数分裂を刺激する少なくとも１つの化合物との組合せ物での不妊治療
CN1341147A (zh) * 1999-02-26 2002-03-20 诺沃挪第克公司 减数分裂活化甾醇增大着床率
IL148234A0 (en) 1999-09-16 2002-09-12 Novo Nordisk As Composition for ivf

Also Published As

Publication number Publication date
AU781994B2 (en) 2005-06-23
WO2001019354A3 (en) 2001-06-14
JP2003509365A (ja) 2003-03-11
UA78183C2 (en) 2007-03-15
ATE306942T1 (de) 2005-11-15
CN1222319C (zh) 2005-10-12
MXPA02002439A (es) 2002-07-30
KR20020032593A (ko) 2002-05-03
PL353968A1 (en) 2003-12-15
EP1216059A2 (en) 2002-06-26
HUP0202630A2 (hu) 2002-12-28
US6844313B1 (en) 2005-01-18
ES2252048T3 (es) 2006-05-16
DE60023324D1 (de) 2005-11-24
WO2001019354A2 (en) 2001-03-22
DE60023324T2 (de) 2006-07-20
RU2263516C2 (ru) 2005-11-10
PL202224B1 (pl) 2009-06-30
CZ2002591A3 (cs) 2002-08-14
KR100757909B1 (ko) 2007-09-11
IL148234A0 (en) 2002-09-12
NO20021309D0 (no) 2002-03-15
AU6985000A (en) 2001-04-17
NO323694B1 (no) 2007-06-25
HUP0202630A3 (en) 2004-06-28
BR0014058A (pt) 2004-03-30
CA2382908A1 (en) 2001-03-22
CN1373675A (zh) 2002-10-09
ZA200201383B (en) 2002-11-27
EP1216059B1 (en) 2005-10-19

Similar Documents

Publication Publication Date Title
ID28965A (id) Azabisikloalkana sebagai modulator ccr5
ID29031A (id) Piperidin sebagai modulator ccr5
DE60010098D1 (de) 28-epirapaloge
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
BR0014352A (pt) Cetoenóis espirocìclicos substituìdos por trifluormetila
LTC1284974I2 (lt) Triazoliltropano dariniai kaip CCR5 moduliatoriai
BR0208338A (pt) Derivados de piridina
DK1143929T3 (da) Biologisk nedbrydelige, pH-termosensitive hydrogeler til langvarig frigivelse af biologisk aktive midler
DE60043447D1 (de) Zusammensetzungen mit kontrollierter freigabe enthaltend nimesulid
SE9901875D0 (sv) Novel compounds
GB0313086D0 (en) Mammalian animal composition
DE69940256D1 (de) Zusammensetzung zur hautbleichung
CL2004001085A1 (es) Compuestos derivados de quinolil propil piperidina, procedimiento de preparacion; compuesto intermediario; composicion farmaceutica, utiles como agentes microbianos.
EE200100503A (et) Meetod suukaudselt manustatava, Tolperisoni või selle soola sisaldava farmatseutilise preparaadi valmistamiseks
BR0007922A (pt) Compostos calcilìticos
NO20021309L (no) Preparat for IVF
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
ITTO20000385A0 (it) Composizione pesticida.
TR199901017A2 (xx) B�cek ilac� terkibi.
SE9904404D0 (sv) Novel composition
EA200100098A1 (ru) Соли пароксетина
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
EE200100489A (et) Resortsinooli kompositsioon
DE10080787D2 (de) Mikrobiozide Zusammensetzung
DK1056755T3 (da) Fungicider

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees